polyene phosphatidylcholine: Clinical Trials

2 trials of polyene phosphatidylcholine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Unknown 1

Follow polyene phosphatidylcholine: new trials by email Literature Review of polyene phosphatidylcholine trials Research Report on polyene phosphatidylcholine

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluate the Efficacy and Safety of AYP-101 for the Reduction of Submental Fat in Chin Area
Polyene Phosphatidylcholine, Matching placebo of AYP-101 - Healthy
Phase 3CompletedAMIpharm Co., Ltd.2522024-03-262026-01-22
The Multi-Center, Randomized, Double-blind, Positive Controlled Clinical Trial of Bicyclol in the Treatment of Acute DILI
bicyclol, 25mg/ tablet, polyene phosphatidylcholine capsules, 228mg/ particle. - Drug-Induced Acute Liver Injury
Phase 3UnknownDrug Induced Liver Disease Study Group3602021-12-202022-08-04

Conditions studied

Chemical and Drug Induced Liver Injury (1)

Sponsors

AMIpharm Co., Ltd. (1)  ·  Drug Induced Liver Disease Study Group (1)

Countries

China (1)  ·  South Korea (1)

Top investigators

Beomjoon Kim, MD (1)  ·  Chengwei Chen (1)  ·  Yimin Mao (1)